PHIO PHARMACEUTICALS CORP (PHIO)
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
$1.08-2.70%
Close 2026-09-04 · 1-day change
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
QuarterlyIQ Insights · PHIO
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of None, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | |||||||||||||||
| Revenues | — | — | — | — | — | — | 0.0 | 0.0 | 0.1 | 0.0 | 0.0 | — | — | 0.4 | 0.1 |
| Total Revenues | — | — | — | — | — | — | 0.0 | 0.0 | 0.1 | 0.0 | 0.0 | — | — | 0.4 | 0.1 |
| Operating Expenses & Income | |||||||||||||||
| R&D Expenses | 8.5 | 4.6 | 3.6 | 6.3 | 7.0 | 8.9 | 3.7 | 4.3 | 4.3 | 5.4 | 5.4 | 6.9 | 5.7 | 17.7 | 10.5 |
| Operating Income | (13.5) | (9.2) | (7.4) | (10.8) | (11.5) | (13.5) | (8.8) | (9.0) | (7.4) | (14.1) | (9.0) | (10.2) | (8.8) | (20.9) | (13.0) |
| Earnings from Continuing Operations | |||||||||||||||
| Other Non-Operating Income / Expenses | — | — | — | (0.0) | (0.0) | 0.2 | (0.0) | 0.1 | 0.0 | (0.0) | 0.0 | 0.0 | — | — | — |
| Asset Writedown | — | — | — | — | — | — | — | — | 0.0 | 0.0 | — | 0.0 | 0.0 | 0.0 | — |
| EBT, Incl. Unusual Items | — | — | — | — | (11.5) | (13.3) | (8.8) | (8.9) | (7.4) | (14.1) | (9.0) | (10.2) | (8.8) | (20.9) | (12.9) |
| Income Tax Expense | — | — | — | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | (1.6) | 0.0 | 0.0 | 0.0 | — | — |
| Net Income | |||||||||||||||
| Net Income | (12.9) | (8.7) | (7.2) | (10.8) | (11.5) | (13.3) | (8.8) | (8.9) | (7.4) | (12.5) | (9.0) | (10.2) | (8.8) | (20.9) | (12.9) |
| Per Share | |||||||||||||||
| Basic EPS | (1.11) | (1.45) | (9.08) | (46.76) | (10.10) | (12.43) | — | — | — | — | — | — | — | — | — |
| Diluted EPS | — | — | (9.08) | (46.76) | (10.10) | (12.43) | — | — | — | — | — | — | — | — | — |
| Basic Weighted Avg Shares | 11.6 | 6.0 | 0.8 | 0.2 | 1.1 | 1.1 | — | — | — | — | — | — | — | — | — |
| Diluted Weighted Avg Shares | — | — | 0.8 | 0.2 | 1.1 | 1.1 | — | — | — | — | — | — | — | — | — |
| Supplemental | |||||||||||||||
| EBITDA | — | (9.2) | (7.4) | (10.8) | (11.4) | 61.5 | 63.2 | (8.9) | (7.3) | (14.0) | (9.0) | (10.2) | (8.7) | (20.9) | (12.8) |
| EBIT | (13.5) | (9.2) | (7.4) | (10.8) | (11.5) | (13.5) | (8.8) | (9.0) | (7.4) | (14.1) | (9.0) | (10.2) | (8.8) | (20.9) | (13.0) |
| Effective Tax Rate | — | — | — | — | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 11.5% | 0.0% | 0.0% | 0.0% | — | — |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.